Cancer.Net Editorial Board

Content on Cancer.Net is approved by the Cancer.Net Editorial Board, composed of more than 150 medical, surgical, radiation, and pediatric oncologists, oncology nurses, physician assistants, social workers, and patient advocates. 

Cancer.Net 2020 Editors Meeting

The Cancer.Net Editors Meeting was held virtually on September 30, 2020. Editor in Chief Lidia Schapira, MD, FASCO, and the site’s Associate Editors reviewed additions and updates to Cancer.Net over the past year, set the 2021 goals for ASCO’s patient education program, and provided expert guidance to ensure that Cancer.Net’s content is comprehensive, credible, current, and accessible for people with cancer.

From top left is Merry Jennifer Markham, MD, FACP, FASCO (Gynecologic Cancer), Ryan Sullivan, MD (Melanoma and Skin Cancer), Karen Winkfield, MD, PhD (Radiation Oncology and Health Equity), and Glenn Lesser, MD, FACP (Central Nervous System Tumors). Second row, from left is Jyoti Patel, MD, FASCO (Lung Cancer), Norah Lynn Henry, MD, PhD, FASCO (Breast Cancer), Lidia Schapira, MD, FASCO, Editor in Chief, and Vicki Keedy, MD (Sarcoma). Third row, from left is Michael Williams, MD, ScM (Lymphoma), Jeffrey Meyerhardt, MD, MPH, FASCO (Gastrointestinal Cancers), Charles Loprinzi, MD, FASCO (Psychosocial Oncology), and Kavitha Ramchandran, MD (Palliative Care). Last row, from left is Irene Ghobrial, MD (Myeloma), Daniel Mulrooney, MD, MS (Pediatric Cancers), Sumanta Pal, MD, FASCO (Genitourinary Cancers), and William Dale, MD, PhD (Geriatric Oncology). 

Not Pictured: Jessica Altman, MD (Leukemia) and Ezra Cohen, MD, FRCPC, FASCO (Head and Neck Cancer).

Associate Editors

View more information about Cancer.Net’s Associate Editors, who lead the Cancer.Net Editorial Board.

Specialty Editors

View more information about Cancer.Net’s Specialty Editors, who provide topic-specific expertise as part of the Cancer.Net Editorial Board.

Advisory Panel

View a listing of Cancer.Net’s full advisory panel, which reviews content as part of the Cancer.Net Editorial Board.